is saxenda glp 1 Regulator keeps close eye on GLP-1 weight loss drugs' possible link to suicidal thoughts < Pharma < Article Novo Nordisk announces Saxenda® (liraglutide

Evidence suggests GLP-1 therapies may modestly lower blood pressure while improving cardiometabolic risk in patients with diabetes and hypertension.

Yuma T, Tokuda M, Nishimoto N, Yokoi H, Izumori K

A pivotal moment occurred in October 2022, just four months after Mounjaros launch, when Elon Musk admitted on Twitter (X) that taking Wegovy was his secret for looking fit and healthy. The post, and a subsequent tweet in 2024 that he was taking Mounjaro, went viral and sparked widespread curiosity around GLP-1s and their effectiveness on weight loss

Sin cuotas de membresa ni otros cargos ocultos!

Serena

Los agonistas del receptor del pptido 1 similar al glucagn muestran beneficios decisivos en peso, control metablico y riesgo cardiovascular, pero su avance revela retos urgentes en seguridad, acceso y sostenibilidad.